SPZCOPLUS THERAPEUTICS, INC. · PSTVData at close 2026-08-07
Health Care · Surgical & Medical Instruments & Apparatus · Nasdaq · CIK 1095981 · FYE Dec 31 · Prices AT CLOSE 2026-08-07 (USD) · STALE: the feed has not advanced this name
PSTV close: $65.3 on 2023-08-07 to $3.8 on 2026-08-07.
Split-adj closes · 240 of 5,141 · price returnⓘ
At a glance
Short interest0.8% of sh out
Days to cover7.8d
13F net flow (QoQ)−0.21%
Top-10 13F concentration96.0%
Next report (est.)2026-11-13
SI 2026-07-31 · 13F 2026-Q1ⓘ
Key fundamentalsFY 2025
Sales (TTM)$4.2M
Earnings (TTM)-$26.1M
Net margin−429.4%
FY ratios · TTM sales/earnings (USD)ⓘ
Trailing returns
YTD−69.9%
1Y−79.8%
3Y−94.1%
5Y−99.5%
10Y−100.0%
Since incept. (ann.)−50.2%
Total return · from 2005-07-11ⓘ
Risk
Ann. volatility (1Y)121.9%
Ann. volatility (3Y)246.5%
Sharpe (1Y)−0.73
Sharpe (3Y)0.33
Max drawdown (1Y)−85.0%
Max drawdown (3Y)−95.8%
Beta (3Y vs SPY)1.93
Daily returns, ann.ⓘ
Top institutional holders13F 2026-Q1
Manager
Shares
Value
% sh out
QoQ
VANGUARD CAPITAL MANAGEMENT LLC
2.4M
$395,617
—
new
GEODE CAPITAL MANAGEMENT, LLC
2.0M
$327,979
—
+43.7%
BlackRock, Inc.
1.8M
$288,838
—
+0.0%
VANGUARD FIDUCIARY TRUST CO
1.2M
$189,695
—
new
STATE STREET CORP
468,893
$76,242
—
+0.0%
NORTHERN TRUST CORP
293,300
$47,691
—
+0.0%
MILLENNIUM MANAGEMENT LLC
271,599
$44,162
—
new
TWO SIGMA SECURITIES, LLC
142,812
$23,221
—
+155.6%
Δ vs 2025-Q4 · % of shares outstanding not shown: no SEC cover-page share count falls within 120 days of the 2026-Q1 quarter end, so any percentage would rest on a count that cannot speak for this quarter. Holder share counts are shown as filed.ⓘ
Latest reported quarterslast report 2026-08-14
Period end
Reported
EPS
EPS YoY
Revenue
Rev YoY
2026-06-30
2026-08-14
−$1.31
—
$411,000
−70.4%
2026-03-31
2026-05-15
−$1.05
—
$1.0M
−2.9%
2025-12-31
2026-03-12
—
—
$1.4M
−3.2%
2025-09-30
2025-10-30
−$0.04
—
$1.4M
−4.1%
As-reported XBRL · next 2026-11-13 est.ⓘ
Basis & disclosures
EOD closes · nothing imputed or averaged · absent “—”
As-of differs by block · 13F = US long, 45+d lag, LOWER bound
Not investment advice · no recommendation, price target or solicitation
EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
